Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase F1 subunit alpha pseudogene 1 (ATP5F1AP1; also known as ATP5A1P1, ATP5A1P5, ATP5A1P6, ATP5AL1, ATP5AP1, et al) is a pseudogene—an inactive copy of the functional gene ATP5F1A—encoding the alpha subunit of the mitochondrial ATP synthase complex [1][3]. The pseudogene does not produce a functional protein and does not directly participate in cellular pathways, biological processes, or disease mechanisms as the protein-coding gene does. The functional ATP5F1A gene's protein product is crucial in mitochondrial ATP synthesis and has well-established roles in energy production and mitochondrial diseases [1][3], but ATP5F1AP1 itself does not encode an active protein and is not considered a therapeutic target.\n\nKey clarification: All referenced functions, roles in disease, and drug interactions for ATP synthase F1 subunit alpha relate to the protein-coding gene ATP5F1A, not to the pseudogene ATP5F1AP1, which is inert and non-protein-coding [1][3]. The presence of multiple aliases and similar names, as well as listing under "pseudogene," indicates it is not a functional molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase F1 subunit alpha pseudogene 1 (ATP5F1AP1).